Natural Capsules Hits Lower Circuit Amid Heavy Selling Pressure

On the trading day, Natural Capsules Ltd (Stock ID: 349207) recorded a day change of -4.08% and a one-day return of -4.97%, contrasting with the Pharmaceuticals & Biotechnology sector’s marginal decline of -0.10% and the Sensex’s positive return of 0.26%. The stock’s intraday low touched ₹186.20, reflecting a near 4% drop from previous levels, while the weighted average price indicated that most volume traded closer to the day’s low price point. This pattern suggests a strong bearish sentiment dominating the trading session.

Liquidity metrics reveal that the total traded volume was approximately 44,590 shares (0.04459 lakhs), with a turnover of ₹0.0829 crore. Despite this, delivery volume plummeted to 27 shares on 18 Nov 2025, a steep fall of 99.26% compared to the five-day average delivery volume, signalling a sharp decline in investor participation. The stock’s trading activity was notably below its moving averages, trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, underscoring a sustained downtrend.

Natural Capsules’ market capitalisation stands at ₹199.00 crore, categorising it as a micro-cap stock within the Pharmaceuticals & Biotechnology industry. The stock’s price band is set at 5%, and on the day in question, it moved down by ₹9.7 from its previous close. The high price recorded was ₹193.89, while the low price was ₹184.19, which also became the last traded price (LTP) as the stock hit its lower circuit limit.

The sharp fall in price and volume dynamics indicate a scenario of panic selling, where unfilled supply overwhelmed demand. The stock’s inability to attract buyers at lower levels, combined with a significant drop in delivery volumes, points to a lack of conviction among investors. This selling pressure has pushed the stock to its maximum permissible daily loss, triggering the lower circuit mechanism designed to curb excessive volatility.

Comparatively, the Pharmaceuticals & Biotechnology sector showed resilience with only a minor decline, and the broader Sensex index closed in positive territory. This divergence highlights that the pressure on Natural Capsules is more stock-specific rather than sector-wide. The company’s Mojo Score, a proprietary metric reflecting various financial and market parameters, stands at 14.0 with a grade of Strong Sell as of 13 Nov 2025, following a revision from a previous Sell grade. This adjustment in evaluation aligns with the recent price action and market sentiment.

Investors should note that the stock’s trading below all key moving averages suggests a persistent bearish trend, which may require a significant catalyst to reverse. The falling investor participation, as evidenced by the drastic drop in delivery volumes, further emphasises the cautious stance adopted by market participants. The stock’s liquidity, while adequate for certain trade sizes, may not support large transactions without impacting price significantly.

From a technical perspective, the stock’s failure to hold above its recent support levels and the breach of multiple moving averages indicate a challenging environment for Natural Capsules. The lower circuit hit acts as a temporary halt to trading, but the underlying supply-demand imbalance remains a concern. Market participants will be closely monitoring upcoming corporate developments, sectoral trends, and broader market cues to gauge any potential recovery.

In conclusion, Natural Capsules Ltd’s performance on 19 Nov 2025 reflects a pronounced selling pressure culminating in the stock hitting its lower circuit limit. The combination of a maximum daily loss of 5.0%, subdued delivery volumes, and trading below all major moving averages paints a picture of cautious investor sentiment and heightened risk. While the Pharmaceuticals & Biotechnology sector and broader market indices showed relative stability, the stock-specific factors have driven this sharp correction. Investors should carefully analyse these dynamics and consider portfolio diversification strategies accordingly.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →